Pro-Dex, Inc. (PDEX) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential
Current Price
$57.42
Price Target
—
Target Range
— — —
Analyst Rating
Buy
Forward P/E24.1x
Trailing P/E21.5x
Forward PEG1.97
Implied Growth-35.2%
Median Target—
Analyst Spread—
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$—
—
Consensus
$—
—
Bull Case
$—
—
Valuation Model TargetsConfidence: 61/100
Bear$18
Base$109
Bull$146
PDEX Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Pro-Dex, Inc. (PDEX) has a Wall Street consensus price target of N/A, based on estimates from 1 covering analysts. The company has a market capitalization of $184M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, PDEX trades at a trailing P/E of 21.5x and forward P/E of 24.1x. The forward PEG ratio of 1.97 indicates reasonable valuation for growth. Analysts expect EPS to grow -35.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $108.52, with bear and bull scenarios of $17.60 and $145.97 respectively. Model confidence stands at 61/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+44.3%
Avg Forward P/E67.1x
Peers with Coverage8 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 NSYSNortech Systems Incorporated | $35M | $12.52 | — | — | — | — | — |
 LIQTLiqTech International, Inc. | $22M | $2.31 | — | — | — | — | — |
 ATRCAtriCure, Inc. | $1.4B | $27.80 | $50.67 | +82.3% | Buy | 370.7x | 19 |
 MMSIMerit Medical Systems, Inc. | $3.7B | $62.33 | $95.00 | +52.4% | Buy | 15.5x | 13 |
 NVCRNovoCure Limited | $1.9B | $16.83 | $33.50 | +99.0% | Buy | — | 15 |
 OSISOSI Systems, Inc. | $4.0B | $241.11 | $293.50 | +21.7% | Buy | 23.0x | 17 |
 SYKStryker Corporation | $112.7B | $294.25 | $403.69 | +37.2% | Buy | 19.6x | 50 |
 ZBHZimmer Biomet Holdings, Inc. | $16.3B | $83.37 | $97.90 | +17.4% | Hold | 9.8x | 42 |
 MDTMedtronic plc | $99.9B | $77.96 | $109.50 | +40.5% | Buy | 14.1x | 49 |
 HOLXHologic, Inc. | $17.0B | $76.01 | $79.00 | +3.9% | Hold | 17.2x | 42 |
Upside Potential Comparison
NVCRATRCMMSIMDTSYKOSISZBHHOLXSee PDEX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PDEX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PDEX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPDEX — Frequently Asked Questions
Quick answers to the most common questions about buying PDEX stock.
What is the PDEX stock price target for 2026?
The consensus price target for PDEX is $N/A, close to the current price of $57.42 (N/A% implied move). Based on 1 analyst estimates, the stock appears fairly valued near current levels.
Is PDEX a buy, sell, or hold?
PDEX has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
Is PDEX stock overvalued or undervalued?
PDEX trades at a forward P/E of 24.1261x, representing a moderate valuation. With analysts targeting $N/A (N/A% implied move), the stock appears close to fair value.
How high can PDEX stock go?
The most bullish Wall Street analyst has a price target of $N/A for PDEX, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $146 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover PDEX stock?
PDEX is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the PDEX stock forecast?
The 12-month PDEX stock forecast based on 1 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $109, with bear/bull scenarios of $18/$146.
What is PDEX's fair value based on fundamentals?
Our quantitative valuation model calculates PDEX's fair value at $109 (base case), with a bear case of $18 and bull case of $146. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 61/100.
What is PDEX's forward P/E ratio?
PDEX trades at a forward P/E ratio of 24.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 21.5x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy PDEX stock?
PDEX appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do PDEX price targets vary so much?
PDEX analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $18-$146 range provides an independent fundamental perspective.